Lessons from the Netherlands for Australia: cross-country comparison of trends in antidepressant dispensing 2013–2021 and contextual factors influencing prescribing
Katharine A. Wallis
A * , Pieter J. S. Dikken A B , Piumika Sooriyaarachchi A , Arthur M. Bohnen B and Maria Donald A
A
B
Abstract
There is concern internationally about increasing antidepressant use. Most antidepressants are prescribed in general practice. The aim of this study was to compare trends in antidepressant dispensing in Australia and the Netherlands over the 9 years from 2013 to 2021, and to explore reasons for differences.
A convergent mixed methods study including analysis of publicly available antidepressant dispensing data obtained from Australia’s Pharmaceutical Benefits Scheme and Repatriation Pharmaceutical Benefits Scheme and the Dutch Foundation for Pharmaceutical Statistics and a search of relevant literature to compare contextual factors influencing prescribing were undertaken.
In 2013, antidepressant dispensing rates in Australia were nearly twice as high as those in the Netherlands (82.5 versus 44.3 DDD/1000/day) and increased to be more than twice as high by 2021 (115.6 versus 48.8 DDD/1000/day). Antidepressant dispensing increased by 40% in Australia over the nine study years, but by only 10% in the Netherlands. Our scan of the literature confirms that while population factors, health system structure, and clinical guideline recommendations are largely consistent across the two countries, a multifaceted approach in the Netherlands involving improved access to non-pharmacological alternatives, initiatives targeting safer antidepressant prescribing, and tight regulation of pharmaceutical industry influence on prescribers, has successfully curtailed increasing antidepressant use.
Australia may learn from the Netherlands’ approach to redress increasing antidepressant use.
Keywords: antidepressant, Australia, clinical guidelines, drug utilisation, general practice, Netherlands, pharmacoepidemiology, policy, prescribing behaviour, quality use of medicines, quantitative research.
References
Abidi L, Oenema A, Verhaak P, Tan FES, van de Mheen D (2019) The introduction of the practice nurse mental health in general practices in the Netherlands: effects on number of diagnoses of chronic and acute alcohol abuse. BMC Family Practice 20, 48.
| Crossref | Google Scholar |
Andrews G, Bell C, Boyce P, Gale C, Lampe L, Marwat O, Rapee R, Wilkins G (2018) Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for the treatment of panic disorder, social anxiety disorder and generalised anxiety disorder. Australian & New Zealand Journal of Psychiatry 52, 1109-1172.
| Crossref | Google Scholar |
Australian Bureau of Statistics (2020) Twenty years of population change. Available at https://www.abs.gov.au/articles/twenty-years-population-change
Australian Bureau of Statistics (2020-21) National study of mental health and wellbeing. Available at https://www.abs.gov.au/statistics/health/mental-health/national-study-mental-health-and-wellbeing/latest-release [Accessed 17 July 2023]
Australian Bureau of Statistics (2023) Population. Available at https://www.abs.gov.au/statistics/people/population [Accessed 23 April 2023]
Australian Government Department of Health and Aged Care (2022) PBS and RPBS Section 85 Date of Supply Data. Available at https://www.pbs.gov.au/info/statistics/dos-and-dop/dos-and-dop
Australian Institute of Health and Welfare (2020) Expenditure on mental health services. Available at https://www.aihw.gov.au/reports/mental-health-services/mental-health-services-in-australia/report-contents/expenditure-on-mental-health-related-services
Australian Medical Association (2018) Doctors’ relationships with industry. Available at https://www.ama.com.au/position-statement/doctors-relationships-industry-2018 [Accessed 30 August 2023]
Centraal Bureau voor de Statistiek (2023a) Population, households and population dynamics; from 1899. Available at https://www.cbs.nl/en-gb/figures/detail/37556eng [Accessed 23 April 2023]
Centraal Bureau voor de Statistiek (2023b) Age distribution. Available at https://www.cbs.nl/en-gb/visualisations/dashboard-population/age/age-distribution
Cochrane Australia (2021) New Cochrane review explores the latest evidence on approaches to stopping long term antidepressants. Available at https://australia.cochrane.org/news/new-cochrane-review-explores-latest-evidence-approaches-stopping-long-term-antidepressants
Coe A, Gunn J, Kaylor-Hughes C (2022) General practice patients’ experiences and perceptions of the WiserAD structured web-based support tool for antidepressant deprescribing: protocol for a mixed methods case study with realist evaluation. JMIR Research Protocols 11, e42526.
| Crossref | Google Scholar | PubMed |
Coe A, Gunn J, Fletcher S, Murray E, Kaylor-Hughes C (2023) Self-reported reasons for reducing or stopping antidepressant medications in primary care: thematic analysis of the diamond longitudinal study. Primary Health Care Research & Development 24, e16.
| Crossref | Google Scholar | PubMed |
Davari M, Khorasani E, Tigabu BM (2018) Factors influencing prescribing decisions of physicians: a review. Ethiopian Journal of Health Sciences 28, 795-804.
| Crossref | Google Scholar |
de Oliveira Costa J, Gillies MB, Schaffer AL, Peiris D, Zoega H, Pearson S-A (2023) Changes in antidepressant use in Australia: a nationwide analysis (2015–2021). Australian & New Zealand Journal of Psychiatry 57, 49-57.
| Crossref | Google Scholar | PubMed |
Donovan J (1999) Advertising pharmaceuticals to Australians. Australian Prescriber 22, 74-75.
| Crossref | Google Scholar |
Dutch National Healthcare Institute (2020) Reimbursment for ATC-subgroup N06A 2016-2020: Antidepressiva | GIPdatabank.nl. Available at https://www.gipdatabank.nl/databank?infotype=g&label=00-totaal&tabel_g_00-totaal=B_01-basis&tabel_h_00-totaal=B_01-basis&geg=vg&spec=&item=N06A
Fabbri A, Grundy Q, Mintzes B, Swandari S, Moynihan R, Walkom E, Bero LA (2017) A cross-sectional analysis of pharmaceutical industry-funded events for health professionals in Australia. BMJ Open 7, e016701.
| Crossref | Google Scholar | PubMed |
Foundation for Pharmaceutical Statistics (2023) Foundation for pharmaceutical statistics – SFK website. Available at https://www.sfk.nl/english/foundation-for-pharmaceutical-statistics [Accessed 23 April 2023]
Gardarsdottir H, Heerdink ER, van Dijk L, Egberts ACG (2007) Indications for antidepressant drug prescribing in general practice in the Netherlands. Journal of Affective Disorders 98, 109-115.
| Crossref | Google Scholar | PubMed |
Greenslit NP, Kaptchuk TJ (2012) Antidepressants and advertising: psychopharmaceuticals in crisis. The Yale Journal of Biology and Medicine 85, 153-158.
| Google Scholar | PubMed |
Hansen AB, Baste V, Hetlevik Ø, Smith-Sivertsen T, Haukenes I, de Beurs D, Nielen M, Ruths S (2022) Comparison of depression care provided in general practice in Norway and the Netherlands: registry-based cohort study (The Norwegian GP-DEP study). BMC Health Services Research 22, 1494.
| Crossref | Google Scholar | PubMed |
Huijbregts KM, Hoogendoorn AW, Slottje P, van Balkom AJLM, Batelaan NM (2017) Long-term and short-term antidepressant use in general practice: data from a large cohort in the Netherlands. Psychotherapy and Psychosomatics 86, 362-369.
| Crossref | Google Scholar | PubMed |
Jorm AF, Nakane Y, Christensen H, Yoshioka K, Griffiths KM, Wata Y (2005) Public beliefs about treatment and outcome of mental disorders: a comparison of Australia and Japan. BMC Medicine 3, 12.
| Crossref | Google Scholar | PubMed |
Kendrick T (2021) Strategies to reduce use of antidepressants. British Journal of Clinical Pharmacology 87, 23-33.
| Crossref | Google Scholar | PubMed |
Magnée T, de Beurs DP, De Bakker DH, Verhaak PF (2016) Consultations in general practices with and without mental health nurses: an observational study from 2010 to 2014. BMJ Open 6, e011579.
| Crossref | Google Scholar | PubMed |
Magnée T, de Beurs DP, Schellevis FG, Verhaak PF (2018) Antidepressant prescriptions and mental health nurses: an observational study in Dutch general practice from 2011 to 2015. Scandinavian Journal of Primary Health Care 36, 47-55.
| Crossref | Google Scholar | PubMed |
Magnée T, Stroo M, Kager C, Hek K (2022) Zet de POH-ggz in bij chronisch medicatiegebruik. Huisarts en wetenschap 65, 29-37.
| Crossref | Google Scholar |
Malhi GS, Bell E, Bassett D, Boyce P, Bryant R, Hazell P, Hopwood M, Lyndon B, Mulder R, Porter R, Singh AB, Murray G (2021) The 2020 Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders. Australian & New Zealand Journal of Psychiatry 55, 7-117.
| Crossref | Google Scholar | PubMed |
McDonald S, Wallis KA, Horowitz M, Mann E, Le V, Donald M (2023) Acceptability and optimisation of resources to support antidepressant cessation: a qualitative think-aloud study with patients. British Journal of General Practice
| Crossref | Google Scholar |
Mcmanus P, Mant A, Mitchell P, Britt H, Dudley J (2003) Use of antidepressants by general practitioners and psychiatrists in Australia. Australian & New Zealand Journal of Psychiatry 37, 184-189.
| Crossref | Google Scholar | PubMed |
McNeill PM, Kerridge IH, Henry DA, Stokes B, Hill SR, Newby D, Macdonald GJ, Day RO, Maguire J, Henderson KM (2006) Giving and receiving of gifts between pharmaceutical companies and medical specialists in Australia. Internal Medicine Journal 36, 571-578.
| Crossref | Google Scholar | PubMed |
Medicines Australia (2020) Code of Conduct. 19th edn. Adopted 26 November 2019. Effective 30 March 2020. Available at https://www.medicinesaustralia.com.au/wp-content/uploads/sites/65/2022/11/20221103-PUB-Edition-19-FINAL-VERSION-2.pdf [Accessed 30 August 2023]
Mintzes B (2021) Policing the promotion of prescription medicines–the new Medicines Australia Code of Conduct. Australian Prescriber 44, 4-5.
| Crossref | Google Scholar | PubMed |
Nederlandse Vereniging voor Psychiatrie (2023) Available at https://www.nvvp.net/home [Accessed 2023]
NHG-werkgroep Depressie (2019) Depressie | NHG-Richtlijnen. Available at https://richtlijnen.nhg.org/standaarden/depressie [Accessed 23 April 2023]
NPS MedicineWise (2022) Medicine costs: how to reduce them. Available at https://www.nps.org.au/consumers/keeping-your-medicines-costs-down
OECDiLibrary (2021) OECD health statistics 2021. Available at https://www.oecd-ilibrary.org/sites/5689c05c-en/index.html?itemId=%2Fcontent%2Fcomponent%2F5689c05c-en
Rowan AN (2023) World happiness report 2023. WellBeing News 5, 1.
| Google Scholar |
Royal Australian College of General Practitioners (2019) Clinical guideline for the diagnosis and management of work-related mental health conditions in general practice. Available at https://www.racgp.org.au/FSDEDEV/media/documents/Clinical%20Resources/Guidelines/Mental%20health/Work-related-mental-health-conditions-in-general-practice.pdf
Ruhe HG, Horikx A, van Avendonk MJP, Groeneweg BF, Mulder H, Woutersen-Koch H (2020) [Discontinuation of SSRIs and SNRIs]. Nederlands tijdschrift voor geneeskunde 164, D4004 Available at http://europepmc.org/abstract/MED/32186829 [Accessed 10 February 2020].
| Google Scholar | PubMed |
Stegge GJ (2004) [Psychiatric training of nurses in the Netherlands since 1883]. Gewina 27, 78-99.
| Google Scholar | PubMed |
Stichting CGR (2023) Code of conduct – Dutch Medicines Act. Available at https://www.cgr.nl/en-GB/Gedragscode-Geneesmiddelenreclame
Therapeutic Goods Administration (2020) Product and consumer medicine information. Available at https://www.tga.gov.au/products/australian-register-therapeutic-goods-artg/consumer-medicines-information-cmi [Accessed 13 May 2023]
Therapeutic Guidelines (2023a) Psychotropic. Available at https://tgldcdp.tg.org.au/guideLine?guidelinePage=Psychotropic&frompage= [Accessed 13 May 2023]
Therapeutic Guidelines (2023b) Stopping an antidepressant. Available at https://tgldcdp.tg.org.au/viewTopic?etgAccess=true&guidelinePage=Psychotropic&topicfile=stopping-antidepressants [Accessed 24 July 2023]
Unemployment Rate (2023) Trading Economic, G20, Unemployment Rate. Available at https://tradingeconomics.com/country-list/unemployment-rate [Accessed 17 August 2023]
Wallis KA, Donald M, Moncrieff J (2021) Antidepressant prescribing in general practice: a call to action. Australian Journal of General Practice 50, 954-956.
| Crossref | Google Scholar | PubMed |
Wallis KA, Donald M, Horowitz M, Moncrieff J, Ware RS, Byrnes J, Thrift K, Cleetus MA, Panahi I, Zwar N, Morgan M, Freeman C, Scott I (2023) RELEASE (REdressing Long-tErm Antidepressant uSE): protocol for a 3-arm pragmatic cluster randomised controlled trial effectiveness-implementation hybrid type-1 in general practice. Trials 24, 615.
| Crossref | Google Scholar | PubMed |
Wammes J, Jeurissen P, Westert G, Tanke M (2020) The Dutch health care system. In ‘International profiles of health care systems’. (Eds R Tikkanen, R Osborn, The Commonwealth Fund, E Mossialos, A Djordjevic, G Wharton, London School of Economics and Political Science) p. 137. (The Commonwealth Fund)
World Health Organization (2023) Defined Daily Dose (DDD). Available at https://www.who.int/tools/atc-ddd-toolkit/about-ddd [Accessed 20 April 2023]
World Population Review (2023) Divorce rates by country 2023. Available at https://worldpopulationreview.com/country-rankings/divorce-rates-by-country [Accessed 17 August 2023]
